Do analysts prefer FEMY or FLGC?

Femasys presently has a consensus price target of $50.00, indicating a potential upside of 1,589.19%. Given Femasys' stronger consensus rating and higher probable upside, research analysts plainly believe Femasys is more favorable than Flora Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, FEMY or FLGC?

Flora Growth has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Femasys $2.29M 10.83 -$18.63M -$3.53 N/A Flora Growth $57.61M 0.09 -$15.91M -$32.49 N/A

Is FEMY or FLGC more profitable?

Flora Growth has a net margin of -32.03% compared to Femasys' net margin of -534.36%. Flora Growth's return on equity of -64.02% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets Femasys -534.36% -225.97% -74.68% Flora Growth -32.03% -64.02% -34.46%

Do analysts prefer FLGC or NVNO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Do analysts rate NXL or FLGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate SINT or FLGC?

Sintx Technologies currently has a consensus target price of $9.33, suggesting a potential upside of 502.15%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than Flora Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate INBS or FLGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Flora Growth (FLGC) Competitors

$4.71 -1.18 (-20.03%)

As of 08/21/2026

Compare

FLGC vs. FEMY, NVNO, NXL, SINT, and INBS

Should you buy Flora Growth stock or one of its competitors? Flora Growth's main competitors and comparable companies include Femasys (FEMY), enVVeno Medical (NVNO), Nexalin Technology (NXL), Sintx Technologies (SINT), and Intelligent Bio Solutions (INBS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Flora Growth compare to Femasys?

Femasys (NASDAQ:FEMY) and Flora Growth (NASDAQ:FLGC) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership.

Flora Growth has a net margin of -32.03% compared to Femasys' net margin of -534.36%. Flora Growth's return on equity of -64.02% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-534.36%	-225.97%	-74.68%
Flora Growth	-32.03%	-64.02%	-34.46%

Femasys has a beta of -2.08, indicating that its stock price is 308% less volatile than the broader market. Comparatively, Flora Growth has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

Flora Growth has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	10.83	-$18.63M	-$3.53	N/A
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A

In the previous week, Femasys had 8 more articles in the media than Flora Growth. MarketBeat recorded 8 mentions for Femasys and 0 mentions for Flora Growth. Femasys' average media sentiment score of 0.28 beat Flora Growth's score of 0.00 indicating that Femasys is being referred to more favorably in the media.

Company	Overall Sentiment
Femasys	Neutral
Flora Growth	Neutral

65.3% of Femasys shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 7.8% of Femasys shares are owned by insiders. Comparatively, 2.3% of Flora Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Femasys presently has a consensus price target of $50.00, indicating a potential upside of 1,589.19%. Given Femasys' stronger consensus rating and higher probable upside, research analysts plainly believe Femasys is more favorable than Flora Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Femasys beats Flora Growth on 9 of the 16 factors compared between the two stocks.

How does Flora Growth compare to enVVeno Medical?

Flora Growth (NASDAQ:FLGC) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

enVVeno Medical has a net margin of 0.00% compared to Flora Growth's net margin of -32.03%. enVVeno Medical's return on equity of -62.28% beat Flora Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
enVVeno Medical	N/A	-62.28%	-56.83%

36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 2.3% of Flora Growth shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Flora Growth has higher revenue and earnings than enVVeno Medical. enVVeno Medical is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A

Flora Growth has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

In the previous week, Flora Growth's average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.

Company	Overall Sentiment
Flora Growth	Neutral
enVVeno Medical	Neutral

Summary

Flora Growth and enVVeno Medical tied by winning 6 of the 12 factors compared between the two stocks.

How does Flora Growth compare to Nexalin Technology?

Nexalin Technology (NASDAQ:NXL) and Flora Growth (NASDAQ:FLGC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Nexalin Technology has higher earnings, but lower revenue than Flora Growth. Nexalin Technology is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nexalin Technology	$300K	24.40	-$8.22M	-$0.48	N/A
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A

In the previous week, Nexalin Technology had 3 more articles in the media than Flora Growth. MarketBeat recorded 3 mentions for Nexalin Technology and 0 mentions for Flora Growth. Nexalin Technology's average media sentiment score of 0.34 beat Flora Growth's score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the media.

Company	Overall Sentiment
Nexalin Technology	Neutral
Flora Growth	Neutral

Nexalin Technology has a beta of 4, meaning that its stock price is 300% more volatile than the broader market. Comparatively, Flora Growth has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Flora Growth has a net margin of -32.03% compared to Nexalin Technology's net margin of -4,141.94%. Flora Growth's return on equity of -64.02% beat Nexalin Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nexalin Technology	-4,141.94%	-278.24%	-218.42%
Flora Growth	-32.03%	-64.02%	-34.46%

0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 16.9% of Nexalin Technology shares are owned by insiders. Comparatively, 2.3% of Flora Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Nexalin Technology beats Flora Growth on 7 of the 13 factors compared between the two stocks.

How does Flora Growth compare to Sintx Technologies?

Sintx Technologies (NASDAQ:SINT) and Flora Growth (NASDAQ:FLGC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

Sintx Technologies has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market. Comparatively, Flora Growth has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market.

In the previous week, Sintx Technologies had 1 more articles in the media than Flora Growth. MarketBeat recorded 1 mentions for Sintx Technologies and 0 mentions for Flora Growth. Sintx Technologies' average media sentiment score of 0.50 beat Flora Growth's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Sintx Technologies	Positive
Flora Growth	Neutral

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 2.3% of Flora Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Sintx Technologies currently has a consensus target price of $9.33, suggesting a potential upside of 502.15%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than Flora Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Sintx Technologies has higher earnings, but lower revenue than Flora Growth. Sintx Technologies is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02M	6.56	-$10.36M	-$4.91	N/A
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A

Flora Growth has a net margin of -32.03% compared to Sintx Technologies' net margin of -848.20%. Flora Growth's return on equity of -64.02% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-848.20%	-354.44%	-115.37%
Flora Growth	-32.03%	-64.02%	-34.46%

Summary

Sintx Technologies beats Flora Growth on 9 of the 16 factors compared between the two stocks.

How does Flora Growth compare to Intelligent Bio Solutions?

Intelligent Bio Solutions (NASDAQ:INBS) and Flora Growth (NASDAQ:FLGC) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Intelligent Bio Solutions has a beta of 4.21, meaning that its share price is 321% more volatile than the broader market. Comparatively, Flora Growth has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Intelligent Bio Solutions had 4 more articles in the media than Flora Growth. MarketBeat recorded 4 mentions for Intelligent Bio Solutions and 0 mentions for Flora Growth. Intelligent Bio Solutions' average media sentiment score of 0.89 beat Flora Growth's score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Intelligent Bio Solutions	Positive
Flora Growth	Neutral

Intelligent Bio Solutions has higher earnings, but lower revenue than Flora Growth. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$4.22M	1.80	-$10.57M	-$9.02	N/A
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 1.3% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 2.3% of Flora Growth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Flora Growth has a net margin of -32.03% compared to Intelligent Bio Solutions' net margin of -294.88%. Flora Growth's return on equity of -64.02% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%
Flora Growth	-32.03%	-64.02%	-34.46%

Summary

Intelligent Bio Solutions and Flora Growth tied by winning 7 of the 14 factors compared between the two stocks.

Get Flora Growth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FLGC vs. The Competition

Export

Metric	Flora Growth	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.93M	$6.02B	$7.37B	$12.85B
Dividend Yield	N/A	1.75%	2.53%	11.08%
P/E Ratio	-0.14	26.67	272.60	24.24
Price / Sales	0.09	45.38	618.96	99.81
Price / Cash	N/A	33.24	78.62	53.99
Price / Book	0.39	6.23	13.05	6.20
Net Income	-$15.91M	$150.07M	$3.47B	$348.59M
7 Day Performance	142.78%	0.69%	2.09%	0.08%
1 Month Performance	188.96%	8.91%	6.64%	3.88%
1 Year Performance	-77.84%	8.07%	25.02%	16.98%

Flora Growth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FLGC Flora Growth	0.137 of 5 stars	$4.71 -20.0%	N/A	-77.8%	$4.93M	$57.61M	N/A	280	Gap Down High Trading Volume
FEMY Femasys	3.1229 of 5 stars	$2.64 +19.8%	$50.00 +1,797.5%	-74.1%	$7.64M	$2.30M	N/A	30	News Coverage Earnings Report Analyst Forecast Gap Down High Trading Volume
NVNO enVVeno Medical	1.4127 of 5 stars	$10.98 -0.6%	N/A	-70.6%	$7.47M	N/A	N/A	30	Gap Down
NXL Nexalin Technology	0.9303 of 5 stars	$0.34 +0.8%	N/A	-67.4%	$7.40M	$217.16K	N/A	3	News Coverage Positive News Analyst Downgrade
SINT Sintx Technologies	2.6214 of 5 stars	$1.64 +0.9%	$9.33 +470.8%	-55.6%	$7.06M	$1.02M	N/A	40

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FLGC) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Flora Growth (FLGC) Competitors

FLGC vs. FEMY, NVNO, NXL, SINT, and INBS

How does Flora Growth compare to Femasys?

Summary

How does Flora Growth compare to enVVeno Medical?

Summary

How does Flora Growth compare to Nexalin Technology?

Summary

How does Flora Growth compare to Sintx Technologies?

Summary

How does Flora Growth compare to Intelligent Bio Solutions?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FLGC vs. The Competition

Flora Growth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Flora Growth (FLGC) Competitors

FLGC vs. FEMY, NVNO, NXL, SINT, and INBS

How does Flora Growth compare to Femasys?

Is FEMY or FLGC more profitable?

Which has more risk and volatility, FEMY or FLGC?

Which has higher valuation & earnings, FEMY or FLGC?

Does the media prefer FEMY or FLGC?

Do institutionals and insiders have more ownership in FEMY or FLGC?

Do analysts prefer FEMY or FLGC?

Summary

How does Flora Growth compare to enVVeno Medical?

Is FLGC or NVNO more profitable?

Do institutionals & insiders have more ownership in FLGC or NVNO?

Which has preferable earnings and valuation, FLGC or NVNO?

Which has more volatility and risk, FLGC or NVNO?

Do analysts prefer FLGC or NVNO?

Does the media favor FLGC or NVNO?

Summary

How does Flora Growth compare to Nexalin Technology?

Which has higher earnings & valuation, NXL or FLGC?

Does the media refer more to NXL or FLGC?

Which has more risk & volatility, NXL or FLGC?

Do analysts rate NXL or FLGC?

Is NXL or FLGC more profitable?

Do insiders & institutionals hold more shares of NXL or FLGC?

Summary

How does Flora Growth compare to Sintx Technologies?

Which has more risk and volatility, SINT or FLGC?

Does the media prefer SINT or FLGC?

Do insiders and institutionals hold more shares of SINT or FLGC?

Do analysts rate SINT or FLGC?

Which has preferable valuation & earnings, SINT or FLGC?

Is SINT or FLGC more profitable?

Summary

How does Flora Growth compare to Intelligent Bio Solutions?

Which has more risk & volatility, INBS or FLGC?

Do analysts rate INBS or FLGC?

Does the media prefer INBS or FLGC?

Which has better valuation & earnings, INBS or FLGC?

Do insiders & institutionals have more ownership in INBS or FLGC?

Is INBS or FLGC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FLGC vs. The Competition

Flora Growth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools